Trump calls out big pharma CEOs, including Indian American Vasant Narasimhan, in push to cut drug prices

Novartis CEO Vasant Narasimhan, a U.S.-trained physician who has led the Swiss pharmaceutical giant since 2018.

White House Press Secretary Karoline Leavitte. / Courtesy of Lalit K Jha

In a rare and direct move, President Donald Trump has personally written to 17 top pharmaceutical CEOs — including Indian American Vasant Narasimhan, MD and CEO of Novartis — demanding urgent action to bring down skyrocketing drug prices in the United States.

The letters, signed by the president and disclosed at a White House briefing on July 31, give companies until Sep.29, 2025, to commit to offering Americans the same prices they charge in Europe and other developed nations. The announcement, delivered by White House Press Secretary Karoline Leavitte, marks a significant escalation in the administration’s war on what it calls “abusive drug pricing practices.”

This post is for paying subscribers only

SUBSCRIBE NOW

Comments

This is a Premium Article, available exclusively to our subscribers.

Read 500+ such News or articles every month by subscribing today!
Monthly

Free

Limited Access

Limited View

Free weekly E-Paper

Subscribe Now
Monthly

$10

Full Access

Unlimited View

Free weekly E-Paper

Free daily newsletter

Subscribe Now
Annual

$50

Full Access

Unlimited View

Free weekly E-Paper

Free daily newsletter

Subscribe Now
Start the conversation

Become a member of New India Abroad to start commenting.

Sign Up Now

Already have an account? Login